Biodesix, Inc.
Biodesix, Inc. (BDSX) Stock Overview
Explore Biodesix, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
113.8M
P/E Ratio
-3.45
EPS (TTM)
$-4.67
ROE
-17.61%
BDSX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Biodesix, Inc. (BDSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.70.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.45 and a market capitalization of 113.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.